Medindia

X

New Study Highlights Current Trends in How the Pharmaceutical Industry Conducts Disease State Awareness Campaigns

Saturday, May 7, 2016 Research News J E 4
Advertisement

CHAPEL HILL, N.C., May 6, 2016 /PRNewswire/ -- Disease state awareness campaigns are one of the few ways to inform patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch.

Disease awareness campaigns have long been used by the pharmaceutical industry to disseminate unbranded information about the characteristics of a particular disease, and how it affects patients. But while some organizations are effectively utilizing disease awareness programs, other companies are struggling to connect their campaigns to their targeted audiences.

To help pharma leaders better understand how to effectively utilize disease awareness programs to support pipeline portfolio products, Best Practices, LLC has published a new research study that delivers reliable industry metrics on current disease state awareness program structure, spend, and activities.

"Disease Awareness Program Excellence: Structure, Activities & Resources Needed for Effective Pipeline Support" identifies what disease awareness activities and investment levels are most effective for supporting pipeline products during both development and post-marketing periods.

The study provides current insights on questions such as:

  • When are companies first using disease awareness programs, and when are they most effective in the product lifecycle?
  • When should you invest the most resources in disease awareness campaigns?
  • Which disease awareness activities are best suited for social media?

Pharmaceutical leaders will be able to use the research results to see how their disease awareness programs stack up against industry averages and trends.

Sixteen leaders at 16 leading pharmaceutical and biotech organizations participated in this study. In addition, one global communications firm representing a biopharma client also participated. Four executives also took part in deep-dive operational interviews.

To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1427.htm.

For related research, visit our Best Practices, LLC website at www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC 

Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-study-highlights-current-trends-in-how-the-pharmaceutical-industry-conducts-disease-state-awareness-campaigns-300264520.html

SOURCE Best Practices, LLC

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
The ART BMC System by Celling Biosciences Is Revol...
S
Intracranial Pressure ICP Monitoring Market (Hospi...